HFA Premium Access

Impact of CHA2DS2-VASc and HAS-BLED on oral anticoagulant use and outcomes in patients with atrial fibrillation and concomitant heart failure: an analysis of 22,055 patients from the SwedeHF

Congress Presentation

About the speaker

Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)
62 presentations
13 followers

13 more presentations in this session

Physical activity measured with implanted devices predicts heart failure outcomes

Speaker: Professor C. Linde (Stockholm, SE)

Thumbnail

Age and effect of implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure.

Speaker: Mrs M. Elming (Copenhagen, DK)

Thumbnail

Use of mineralocorticoid receptor antagonists in a real-world population with heart failure and reduced ejection fraction: an analysis of 24,529 patients from the swedish heart failure registry

Speaker: Doctor G. Savarese (Stockholm, SE)

Thumbnail

Oral anticoagulant use in patients with atrial fibrillation and concomitant heart failure: an analysis of 22,719 patients from the swedish heart failure registry

Speaker: Doctor G. Savarese (Stockholm, SE)

Thumbnail

SGLT2 inhibition differentially reduces extracellular fluid volume relative to blood volume: a hypothesis for heart failure protection

Speaker: Assistant Professor M. Hallow (Athens, GA, US)

Thumbnail

Access the full session

Rapid Fire 4 - Therapy and management

Speakers: Professor G. Savarese, Professor C. Linde, Mrs M. Elming, Doctor G. Savarese, Doctor G. Savarese...
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

ESC 365 is supported by